Three cannabis extracts with different THC/CBD ratios all inhibited LDL oxidation, foam cell formation, and inflammatory pathway activation through non-traditional cannabinoid receptors.
Cardiovascular researchers, cannabinoid pharmacologists, and atherosclerosis scientists.
What the researchers found
Three extracts (high, intermediate, low THC/CBD) all inhibited LDL oxidation and foam cell formation (ED50 5-12 ug/mL). Effects independent of CB1/CB2, operating through TRPV1, TRPV4, GPR55 and calcium signaling. Decreased CD36 and OLR1 via NFkB inhibition.
Why it matters
Atherosclerosis is the leading cause of death. These findings identify phytocannabinoids as multi-target plaque formation inhibitors working through non-traditional pathways.
The numbers in context
Three extracts tested. All inhibited LDL oxidation and foam cell formation. ED50: 5-12 ug/mL. Via TRPV1, TRPV4, GPR55, not CB1/CB2. NFkB pathway inhibition.
How the study worked
In vitro study testing three cannabis extracts against LDL oxidation, foam cell formation by J774 macrophages, and inflammatory signaling using receptor antagonists.
What this study cannot tell us
Entirely in vitro. Effective concentrations may not be achievable in vivo. Cannot predict human atherosclerosis outcomes.
How to read the evidence
Mechanistically rigorous in vitro study but entirely cell-based with no in vivo data.
When this study was published
2024 publication.
The bigger picture
Most cannabinoid research focuses on CB1/CB2 receptors. This reveals cardiovascular mechanisms through entirely different pathways.
Questions still open
- Would oral cannabis achieve sufficient vascular concentrations?
- Could targeted formulations provide cardiovascular protection without psychoactive effects?
Common questions
Can cannabis prevent heart disease?
Why did all three extracts work?
Read the original research
Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development.
PloS one, 19(12), e0310777
Citation
Musetti, Bruno; Kun, Alejandra; Menchaca, David; Rodríguez-Haralambides, Alejandra; Varela, Javier; Thomson, Leonor; Bahnson, Edward M. (2024). Cannabis sativa extracts inhibit LDL oxidation and the formation of foam cells in vitro, acting as potential multi-step inhibitors of atherosclerosis development.. PloS one, 19(12), e0310777. https://doi.org/10.1371/journal.pone.0310777
Explore the wider topic
- Cannabis and Your Cardiovascular System: Heart Risk, Stroke, and What the Research Shows
- Cannabis and Your Heart: What the Cardiovascular Research Shows
- Coughing Up Black Stuff After Quitting Weed: What It Means
- Lung Recovery After Quitting Weed: The Complete Timeline
- Weed and Your Lungs: Recovery Timeline After Quitting
- Quitting Weed as a Woman: Hormones, Cycles, and Recovery
- Cannabis, Weight, and Diet: What Quitting Does to Your Appetite
- Sex After Quitting Weed: What Changes and What Doesn't
- Cannabis and Driving: DUI Laws, Impairment Science, and What You Need to Know
- Weed and Acne: Can Quitting Cannabis Clear Your Skin?
- Weed and Fertility: What Couples Should Know
- Weed and Your Gut: How Cannabis Affects Digestion
- Weed and Your Heart: Cardiovascular Effects and Recovery
- Weed, Testosterone, and Male Health: What the Research Actually Shows